相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development
Andreas Friebe et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
Livio Casarini et al.
ISCIENCE (2020)
Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation
Ting Lan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Probing the Effect of Sildenafil on Progesterone and Testosterone Production by an Intracellular FRET/BRET Combined Approach
Livio Casarini et al.
BIOCHEMISTRY (2019)
Type II cGMP-dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells
Min Wu et al.
MOLECULAR MEDICINE REPORTS (2017)
Bright Bioluminescent BRET Sensor Proteins for Measuring Intracellular Caspase Activity
Anniek den Hamer et al.
ACS SENSORS (2017)
β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG
Kevin Lee et al.
ONCOTARGET (2016)
The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma
Traci R. Tuttle et al.
CANCER LETTERS (2016)
Sildenafil Potentiates a cGMP-Dependent Pathway to Promote Melanoma Growth
Sandeep Dhayade et al.
CELL REPORTS (2016)
Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα
Thomas M. Moon et al.
CHEMISTRY & BIOLOGY (2015)
cGMP signaling as a target for the prevention and treatment of breast cancer
Perrin F. Windham et al.
SEMINARS IN CANCER BIOLOGY (2015)
Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells
Ying Wang et al.
ONCOLOGY LETTERS (2015)
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells
Marialuisa Sponziello et al.
ENDOCRINE (2015)
Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors
W-K Tsai et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2014)
Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells
Yu Ren et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Interlude of cGMP and cGMP/Protein Kinase G Type 1 in Pancreatic Adenocarcinoma Cells
Svetlana Karakhanova et al.
PANCREAS (2014)
Sildenafil Use and Increased Risk of Incident Melanoma in US Men A Prospective Cohort Study
Wen-Qing Li et al.
JAMA INTERNAL MEDICINE (2014)
Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells
Min Wu et al.
ONCOLOGY LETTERS (2013)
NOS-2 signaling and cancer therapy
Ka Bian et al.
IUBMB LIFE (2012)
Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines
Faranak Fallahian et al.
FEBS JOURNAL (2011)
Colon Tumor Cell Growth-Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition
Heather N. Tinsley et al.
CANCER PREVENTION RESEARCH (2010)
Estrogen-Induced Apoptosis of Breast Epithelial Cells Is Blocked by NO/cGMP and Mediated by Extranuclear Estrogen Receptors
Irida Kastrati et al.
ENDOCRINOLOGY (2010)
Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation
Kalpana Mujoo et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2010)
Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia
Boon Hwa Neo et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2010)
Tumour cell survival signalling by the ERK1/2 pathway
K. Balmanno et al.
CELL DEATH AND DIFFERENTIATION (2009)
The GAF domain of the cGMP-Binding, cGMP-specific phosphodiesterase (PDE5) is a sensor and a sink for cGMP
Kabir Hassan Biswas et al.
BIOCHEMISTRY (2008)
The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
N. Mehrotra et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization
Mitsi A. Blount et al.
MOLECULAR PHARMACOLOGY (2006)
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells
M Fraser et al.
ONCOGENE (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Caspases-2, -3, and -7 are involved in thapsigargin-induced apoptosis of SH-SY5Y neuroblastoma cells
MK Dahmer
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
The PAX8/PPARc fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARc inhibition
JG Powell et al.
ONCOGENE (2004)
Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation
MA Blount et al.
MOLECULAR PHARMACOLOGY (2004)
Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells
A Deguchi et al.
CANCER RESEARCH (2004)
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
SD Rybalkin et al.
EMBO JOURNAL (2003)
Central role of glycogen synthase kinase-3β in endoplasmic reticulum stress-induced caspase-3 activation
L Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide
C De Nadai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
